Clinical Microbiology and Infection

Article	Citations
Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis	1057
Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review	625
Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study	602
Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis	551
Follow-up of adults with noncritical COVID-19 two months after symptom onset	510
Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study	488
Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting	484
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society	428
Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis	306
European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults	304
Female gender is associated with long COVID syndrome: a prospective cohort study	296
Novel SARS-CoV-2 variants: the pandemics within the pandemic	288
SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis	268
BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel	258
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors	238
Impact of COVID-19 on maternal and neonatal outcomes: a systematic review and meta-analysis	236
Saliva sample as a non-invasive specimen for the diagnosis of coronavirus disease 2019: a cross-sectional study	233
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain	219
Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients	215
Field evaluation of a rapid antigen test (Panbio™ COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centres	204
Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis	196
Viable SARS-CoV-2 in various specimens from COVID-19 patients	182
Antibody response to SARS-CoV-2 mRNA vaccine among kidney transplant recipients: a prospective cohort study	173
Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study	146
Recommendations for antibacterial therapy in adults with COVID-19 – an evidence based guideline	143

Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-CoV-2 infection	143
Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis	142
2020 list of human papillomavirus assays suitable for primary cervical cancer screening	141
Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity	138
Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review	138
Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European Confederation of Medical Mycology	132
Validation of a commercially available SARS-CoV-2 serological immunoassay	130
How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST)	128
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1	127
Outbreak of Candida auris infection in a COVID-19 hospital in Mexico	127
Machine learning for microbial identification and antimicrobial susceptibility testing on MALDI-TOF mass spectra: a systematic review	124
Post–COVID-19 chronic symptoms: a postinfectious entity?	119
Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by four automated immunoassays and three ELISAs	118
Anosmia in COVID-19 patients	116
ESCMID COVID-19 living guidelines: drug treatment and clinical management	110
Clinical characteristics of ambulatory and hospitalized patients with monkeypox virus infection: an observational cohort study	108
The interface between COVID-19 and bacterial healthcare-associated infections	106
Understanding the role of bacterial and fungal infection in COVID-19	104
A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients	104
Evaluation of a rapid antigen test (Panbio™ COVID-19 Ag rapid test device) for SARS-CoV-2 detection in asymptomatic close contacts of COVID-19 patients	103
How to interpret and use COVID-19 serology and immunology tests	103
How do I manage nocardiosis?	101
Antibody responses to BNT162b2 mRNA COVID-19 vaccine and their predictors among healthcare workers in a tertiary referral hospital in Japan	100
Stigma at the time of the COVID-19 pandemic	100
The role of asymptomatic and pre-symptomatic infection in SARS-CoV-2 transmission—a living systematic review	99
Detection and infectivity potential of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) environmental contamination in isolation units and quarantine facilities	99
Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort	97
Pulmonary long-term consequences of COVID-19 infections after hospital discharge	95
Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study	94
Nationwide effectiveness of five SARS-CoV-2 vaccines in Hungary—the HUN-VE study	93
Quantitative SARS-CoV-2 anti-spike responses to Pfizer–BioNTech and Oxford–AstraZeneca vaccines by previous infection status	93
Clinical course and factors associated with outcomes among 1904 patients hospitalized with COVID-19 in Germany: an observational study	92
Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis	92
Incidence of invasive pulmonary aspergillosis among critically ill COVID-19 patients	88
Clinical course and outcomes of critically ill patients with COVID-19 infection: a systematic review	88
Neurologic manifestations associated with COVID-19: a multicentre registry	87
Evolution of viral quasispecies during SARS-CoV-2 infection	87
Risk factors associated with COVID-19-associated pulmonary aspergillosis in ICU patients: a French multicentric retrospective cohort	86
Characteristics of 1573 healthcare workers who underwent nasopharyngeal swab testing for SARS-CoV-2 in Milan, Lombardy, Italy	83
Antibiotic resistance associated with the COVID-19 pandemic: a systematic review and meta-analysis	81
Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concerns	80
ESCMID rapid guidelines for assessment and management of long COVID	79
Machine learning in the clinical microbiology laboratory: has the time come for routine practice?	78
Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)	77
Pre-exposure prophylaxis with tixagevimab and cilgavimab (Evusheld) for COVID-19 among 1112 severely immunocompromised patients	76
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19	75
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy	74
Antifungal therapeutic drug monitoring: focus on drugs without a clear recommendation	73
Performance of a novel diagnostic assay for rapid SARS-CoV-2 antigen detection in nasopharynx samples	72
Cardiac sequelae after coronavirus disease 2019 recovery: a systematic review	72

Risk factors for carbapenem-resistant Gram-negative bacterial infections: a systematic review	71
Excretion of SARS-CoV-2 in human breast milk	71
Onset, duration and unresolved symptoms, including smell and taste changes, in mild COVID-19 infection: a cohort study in Israeli patients	71
Machine learning in infection management using routine electronic health records: tools, techniques, and reporting of future technologies	70
Serology anno 2021—fungal infections: from invasive to chronic	69
Investigating the impact of COVID-19 on primary care antibiotic prescribing in North West London across two epidemic waves	68
Efficacy of favipiravir in adults with mild COVID-19: a randomized, double-blind, multicentre, placebo-controlled clinical trial	67
Multicenter evaluation of the Panbio™ COVID-19 rapid antigen-detection test for the diagnosis of SARS-CoV-2 infection	67
Has the mortality from pulmonary mucormycosis changed over time? A systematic review and meta-analysis	66
Systematic review on estimated rates of nephrotoxicity and neurotoxicity in patients treated with polymyxins	66
Impact of time to antibiotic therapy on clinical outcome in patients with bacterial infections in the emergency department: implications for antimicrobial stewardship	65
Culture-independent detection systems for bloodstream infection	65
Seven-versus 14-day course of antibiotics for the treatment of bloodstream infections by Enterobacterales: a randomized, controlled trial	65
Cross-resistance to cefiderocol and ceftazidime–avibactam in KPC β-lactamase mutants and the inoculum effect	64
Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks	62
Nucleic acid amplification tests on respiratory samples for the diagnosis of coronavirus infections: a systematic review and meta-analysis	61
Dynamic SARS-CoV-2-specific B-cell and T-cell responses following immunization with an inactivated COVID-19 vaccine	60
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study)	60
Predictors of progression from moderate to severe coronavirus disease 2019: a retrospective cohort	59
How to: perform antifungal susceptibility testing of microconidia-forming dermatophytes following the new reference EUCAST method E.Def 11.0, exemplified by Trichophyton	59
Long COVID-19—it's not over until?	59
Exposure to World Health Organization's AWaRe antibiotics and isolation of multidrug resistant bacteria: a systematic review and meta-analysis	58
Antimicrobial susceptibility testing of Mycobacterium tuberculosis complex isolates – the EUCAST broth microdilution reference method for MIC determination	57
Detection of multiple hypervirulent Klebsiella pneumoniae strains in a New York City hospital through screening of virulence genes	55
Defining COVID-19–associated pulmonary aspergillosis: systematic review and meta-analysis	55
Remdesivir for the treatment of COVID-19: a systematic review and meta-analysis	54
SARS-CoV-2 ACE-receptor detection in the placenta throughout pregnancy	54
Early antibody response in health-care professionals after two doses of SARS-CoV-2 mRNA vaccine (BNT162b2)	53
Update on SARS-CoV-2 seroprevalence: regional and worldwide	53
CT lung lesions as predictors of early death or ICU admission in COVID-19 patients	53
Virus shedding dynamics in asymptomatic and mildly symptomatic patients infected with SARS-CoV-2	52
Image analysis and artificial intelligence in infectious disease diagnostics	52
The potential clinical utility of measuring severe acute respiratory syndrome coronavirus 2-specific T-cell responses	52
Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study	52
Estimating daily antibiotic harms: an umbrella review with individual study meta-analysis	52
Early detection of SARS-CoV-2 infection cases or outbreaks at nursing homes by targeted wastewater tracking	52
Socioeconomic disparities and COVID-19 vaccination acceptance: a nationwide ecologic study	51
Long-term persistence of olfactory and gustatory disorders in COVID-19 patients	51
SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay	51
Microbiology of hip and knee periprosthetic joint infections: a database study	51
Disappearance of antibodies to SARS-CoV-2 in a -COVID-19 patient after recovery	51
Differences in environmental stability among SARS-CoV-2 variants of concern: both omicron BA.1 and BA.2 have higher stability	51
Effects of tocilizumab on mortality in hospitalized patients with COVID-19: a multicentre cohort study	51
Invasive pulmonary fusariosis in an immunocompetent critically ill patient with severe COVID-19	50
Prolonged SARS-CoV-2 cell culture replication in respiratory samples from patients with severe COVID-19	50
The WHO essential medicines list AWaRe book: from a list to a quality improvement system	49
Antibiotics versus no therapy in kidney transplant recipients with asymptomatic bacteriuria (BiRT): a pragmatic, multicentre, randomized, controlled trial	49
Highly sensitive and specific detection of hepatitis B virus DNA and drug resistance mutations utilizing the PCR-based CRISPR-Cas13a system	48
Quantifying the transmission of antimicrobial resistance at the human and livestock interface with genomics	48
Specificity and positive predictive value of SARS-CoV-2 nucleic acid amplification testing in a low-prevalence setting	48
Multicentric evaluation of BioFire FilmArray Pneumonia Panel for rapid bacteriological documentation of pneumonia	47
Real-world safety data for the Pfizer BNT162b2 SARS-CoV-2 vaccine: historical cohort study	47
Timing of SARS-CoV-2 vaccination during the third trimester of pregnancy and transplacental antibody transfer: a prospective cohort study	47
Lower respiratory tract infection in the community: associations between viral aetiology and illness course	47
Antibiotic use in the COVID-19 crisis in Spain	47
Predictors and microbiology of respiratory and bloodstream bacterial infection in patients with COVID-19: living rapid review update and meta-regression	46
Early outcome and safety of bedaquiline-containing regimens for treatment of MDR- and XDR-TB in China: a multicentre study	46
The kinetics of viral load and antibodies to SARS-CoV-2	45
Invasive aspergillosis in patients with severe COVID-19 pneumonia	45
Molecular diagnosis of polymicrobial brain abscesses with 16S-rDNA-based next-generation sequencing	44
In vivo emergence of high-level resistance during treatment reveals the first identified mechanism of amphotericin B resistance in Candida auris	44
Antibody response induced by the BNT162b2 mRNA COVID-19 vaccine in a cohort of health-care workers, with or without prior SARS-CoV-2 infection: a prospective study	44
Bacillus Calmette-Guérin vaccine to reduce healthcare worker absenteeism in COVID-19 pandemic, a randomized controlled trial	43
Predicting Pseudomonas aeruginosa susceptibility phenotypes from whole genome sequence resistome analysis	43
Pseudomonas aeruginosa and lung function decline in patients with bronchiectasis	43
Dynamics and predisposition of respiratory viral co-infections in children and adults	43
Molecular analysis of clinical isolates of ceftazidime-avibactam-resistant Klebsiella pneumoniae	43
Non-invasive saliva specimens for the diagnosis of COVID-19: caution in mild outpatient cohorts with low prevalence	43
Diagnostic accuracy of point-of-care tests in acute community-acquired lower respiratory tract infections. A systematic review and meta-analysis	43
Co-infection with other respiratory pathogens in COVID-19 patients	42
The seroprevalence of SARS-CoV-2 antibodies among health care workers before the era of vaccination: a systematic review and meta-analysis	42
Self-testing for the detection of SARS-CoV-2 infection with rapid antigen tests for people with suspected COVID-19 in the community	42
Effectiveness of mRNA-BNT162b2, mRNA-1273, and ChAdOx1 nCoV-19 vaccines against COVID-19 in healthcare workers: an observational study using surveillance data	41
Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives	41
Clinical outcome in solid organ transplant recipients affected by COVID-19 compared to general population: a systematic review and meta-analysis	41
COVID-19–associated mucormycosis: a systematic review and meta-analysis of 958 cases	41
Assessment of prevalence and load of torquetenovirus viraemia in a large cohort of healthy blood donors	40
Silent spread of mobile colistin resistance gene mcr-9.1 on IncHI2 ‘superplasmids’ in clinical carbapenem-resistant Enterobacterales	40
A host signature based on TRAIL, IP-10, and CRP for reducing antibiotic overuse in children by differentiating bacterial from viral infections: a prospective, multicentre cohort study	40
Comparison of disk diffusion, MIC test strip and broth microdilution methods for cefiderocol susceptibility testing on carbapenem-resistant enterobacterales	40

Obesity, diabetes, hypertension and severe outcomes among inpatients with coronavirus disease 2019: a nationwide study	39
Prevalence of SARS-CoV-2 IgG antibodies in an area of northeastern Italy with a high incidence of COVID-19 cases: a population-based study	39
Clinical outcomes of the severe acute respiratory syndrome coronavirus 2 Omicron and Delta variant: systematic review and meta-analysis of 33 studies covering 6 037 144 coronavirus disease 2019–positi	39
Pretomanid for tuberculosis: a systematic review	39
Fluconazole-resistant Candida parapsilosis clonally related genotypes: first report proving the presence of endemic isolates harbouring the Y132F ERG11 gene substitution in Spain	39
Safety and immunogenicity of SpikoGen®, an Advax-CpG55.2-adjuvanted SARS-CoV-2 spike protein vaccine: a phase 2 randomized placebo-controlled trial in both seropositive and seronegative populations	39
How do I manage a patient with enterococcal bacteraemia?	38
Saliva for molecular detection of SARS-CoV-2 in school-age children	38
Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network Cohort	38
SARS-CoV-2 N gene dropout and N gene Ct value shift as indicator for the presence of B.1.1.7 lineage in a commercial multiplex PCR assay	38
Dramatically improved hand hygiene performance rates at time of coronavirus pandemic	37
Elevation of serum ferritin levels for predicting a poor outcome in hospitalized patients with influenza infection	37
How to conduct a systematic review and meta-analysis of prognostic model studies	37
Time to blood culture positivity in Staphylococcus aureus bacteraemia to determine risk of infective endocarditis	37
National surveillance of bacterial and fungal coinfection and secondary infection in COVID-19 patients in England: lessons from the first wave	37
Bloodstream infections in patients with rectal colonization by Klebsiella pneumoniae producing different type of carbapenemases: a prospective, cohort study (CHIMERA study)	36
The impact of COVID-19 on community antibiotic use in Canada: an ecological study	36
Personal protective equipment protecting healthcare workers in the Chinese epicentre of COVID-19	36
Non-occupational and occupational factors associated with specific SARS-CoV-2 antibodies among hospital workers – A multicentre cross-sectional study	36
Therapeutic strategies for severe COVID-19: a position paper from the Italian Society of Infectious and Tropical Diseases (SIMIT)	36
Post–COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients	35
Sars-Cov-2 antigen tests predict infectivity based on viral culture: comparison of antigen, PCR viral load, and viral culture testing on a large sample cohort	35
Resistance mutations in SARS-CoV-2 omicron variant in patients treated with sotrovimab	35
Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance	35
COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it?	35
Whole-genome sequencing for surveillance of tuberculosis drug resistance and determination of resistance level in China	35
The ongoing Streptococcus pyogenes (Group A Streptococcus) outbreak in London, United Kingdom, in December 2022: a molecular epidemiology study	34
Disinfectant effectiveness against SARS-CoV-2 and influenza viruses present on human skin: model-based evaluation	34
Characteristics associated with serological COVID-19 vaccine response and durability in an older population with significant comorbidity: the Danish Nationwide ENFORCE Study	34
Proton pump inhibitor use and risk for recurrent Clostridioides difficile infection: a systematic review and meta-analysis	34
PRAISE: providing a roadmap for automated infection surveillance in Europe	34
Antimicrobial stewardship in the emergency department: characteristics and evidence for effectiveness of interventions	34
ESCMID/EUCIC clinical practice guidelines on perioperative antibiotic prophylaxis in patients colonized by multidrug-resistant Gram-negative bacteria before surgery	34
Epidemiology, evolution and cryptic susceptibility of methicillin-resistant Staphylococcus aureus in China: a whole-genome-based survey	34
Clinical characteristics and factors associated with hospital admission or death in 43 103 adult outpatients with coronavirus disease 2019 managed with the Covidom telesurveillance solution: a prospec	33
Rate and severity of suspected SARS-Cov-2 reinfection in a cohort of PCR-positive COVID-19 patients	33
Azole resistance survey on clinical Aspergillus fumigatus isolates in Spain	33
Short-course antibiotics for common infections: what do we know and where do we go from here?	33
Immunogenicity of COVID-19 vaccines in solid organ transplant recipients: a systematic review and meta-analysis	33
Sample pooling for SARS-CoV-2 RT-PCR screening	33
COVID-19–Associated cardiac pathology at the postmortem evaluation: a collaborative systematic review	33
Incidence and outcomes of infective endocarditis after transcatheter aortic valve implantation versus surgical aortic valve replacement	32
Relative bradycardia in patients with COVID-19	32
Saliva collected in universal transport media is an effective, simple and high-volume amenable method to detect SARS-CoV-2	32
Diagnostic accuracy of loop-mediated isothermal amplification coupled to nanopore sequencing (LamPORE) for the detection of SARS-CoV-2 infection at scale in symptomatic and asymptomatic populations	32
Length of hospital stay and risk of intensive care admission and in-hospital death among COVID-19 patients in Norway: a register-based cohort study comparing patients fully vaccinated with an mRNA vac	31
Epidemiological and clinical characteristics of SARS-CoV-2 infections at a testing site in Berlin, Germany, March and April 2020—a cross-sectional study	31
Recommendations for accurate genotyping of SARS-CoV-2 using amplicon-based sequencing of clinical samples	31
Not all COVID-19 pandemic waves are alike	31
Low-to-moderate dose corticosteroids treatment in hospitalized adults with COVID-19	31
Public opinion on a mandatory COVID-19 vaccination policy in France: a cross-sectional survey	31
Evaluation of the Biofire FilmArray meningitis/encephalitis assay for the detection of Cryptococcus neoformans/gattii	31
The association between bacteria colonizing the upper respiratory tract and lower respiratory tract infection in young children: a systematic review and meta-analysis	31
Factors associated with asymptomatic infection in health-care workers with severe acute respiratory syndrome coronavirus 2 infection in Wuhan, China: a multicentre retrospective cohort study	30
How to: ECOFFs—the why, the how, and the don'ts of EUCAST epidemiological cutoff values	30
Evidence of co-infections during Delta and Omicron SARS-CoV-2 variants co-circulation through prospective screening and sequencing	30
Nationwide outbreak of invasive listeriosis associated with consumption of meat products in health care facilities, Germany, 2014–2019	30
Prognostic factors for severe and recurrent Clostridioides difficile infection: a systematic review	30
Interventions for rapid recognition and treatment of sepsis in the emergency department: a narrative review	30
Non-invasive diagnosis of Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis	29
Antibiotic heteroresistance in ESKAPE pathogens, from bench to bedside	29
SARS-CoV-2 infection: the environmental endurance of the virus can be influenced by the increase of temperature	29
FAM19A4/miR124-2 methylation analysis as a triage test for HPV-positive women: cross-sectional and longitudinal data from a Dutch screening cohort	29
Caring for older adults during the COVID-19 pandemic	29
Decreased prevalence rate of respiratory pathogens in hospitalized patients during the COVID-19 pandemic: possible role for public health containment measures?	29
Prospective One Health genetic surveillance in Vietnam identifies distinct blaCTX-M-harbouring Escherichia coli in food-chain and human-derived samples	29
Investigating infection management and antimicrobial stewardship in surgery: a qualitative study from India and South Africa	29
Spreading of a new SARS-CoV-2 N501Y spike variant in a new lineage	29
Evaluating the efficacy and safety of SpikoGen®, an Advax-CpG55.2–adjuvanted severe acute respiratory syndrome coronavirus 2 spike protein vaccine: a phase 3 randomized placebo-controlled trial	29
Transmission of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) from pre and asymptomatic infected individuals: a systematic review	29
Long-term neurologic and cognitive outcome and quality of life in adults after pneumococcal meningitis	29
SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects	29
Effect of the coronavirus disease 2019 pandemic on antibiotic use in primary care	28
Impact of meningococcal ACWY conjugate vaccines on pharyngeal carriage in adolescents: evidence for herd protection from the UK MenACWY programme	28
Hydroxychloroquine in mild-to-moderate coronavirus disease 2019: a placebo-controlled double blind trial	28
Rapid diagnostic tests for infectious diseases in the emergency department	28
Towards clinical breakpoints for non-tuberculous mycobacteria – Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilutio	28
Risk factors for candidaemia in hospitalized patients with liver cirrhosis: a multicentre case–control–control study	28
Use of an antiviral mouthwash as a barrier measure in the SARS-CoV-2 transmission in adults with asymptomatic to mild COVID-19: a multicentre, randomized, double-blind controlled trial	27
A clinical predictive model of candidaemia by Candida auris in previously colonized critically ill patients	27
Prevalence of COVID-19 in Iran: results of the first survey of the Iranian COVID-19 Serological Surveillance programme	27
One Health: a multifaceted concept combining diverse approaches to prevent and control antimicrobial resistance	27
Sample pooling: burden or solution?	27
Effect of tocilizumab, sarilumab, and baricitinib on mortality among patients hospitalized for COVID-19 treated with corticosteroids: a systematic review and meta-analysis	26
Tocilizumab for coronavirus disease 2019 in pregnancy and lactation: a narrative review	26
Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM—a prospective, randomized, single-centre, open-label study	26
Challenges towards serologic diagnostics of emerging arboviruses	26
Influence of treatment with neutralizing monoclonal antibodies on the SARS-CoV-2 nasopharyngeal load and quasispecies	26
Surveillance strategies using routine microbiology for antimicrobial resistance in low- and middle-income countries	26
Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis, first update	26
High prevalence of heterotopic ossification in critically ill patients with severe COVID-19	26
Hepatitis B virus and hepatitis C virus reactivation in cancer patients receiving novel anticancer therapies	26
Cytomegalovirus infection in transplant recipients: newly approved additions to our armamentarium	26
COVID-19 vaccination in Israel	26
Outpatient convalescent plasma therapy for high-risk patients with early COVID-19: a randomized placebo-controlled trial	25